Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Cash and Equivalents of $1.42 million for fiscal year 2023.
CHINA PHARMA HOLDINGS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2023 | $1.42M | -29.9% |
| 2022 | $2.03M | -58.2% |
| 2021 | $4.86M | +407.4% |
| 2020 | $957.7K | -10.9% |
| 2019 | $1.07M | -9.4% |
| 2018 | $1.19M | -41.6% |
| 2017 | $2.03M | -23.8% |
| 2016 | $2.67M | -57.3% |
| 2015 | $6.25M | +55.1% |
| 2012 | $4.03M | -0.5% |
| 2011 | $4.05M | +9.7% |
| 2010 | $3.69M | +1.6% |
| 2009 | $3.63M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $267.6K | — | -57.3% |
| December 31, 2024 | $626.9K | — | -54.2% |
| September 30, 2023 | $1.37M | -34.3% | +51.9% |
| June 30, 2023 | $901.9K | -59.8% | -22.7% |
| March 31, 2023 | $1.17M | -68.6% | -42.5% |
| December 31, 2022 | $2.03M | -58.2% | -2.7% |
| September 30, 2022 | $2.09M | +354.7% | -7.1% |
| June 30, 2022 | $2.24M | +27.9% | -39.6% |
- CHINA PHARMA HOLDINGS, INC. showed a decrease of -29.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2023 period, CHINA PHARMA HOLDINGS, INC.’s cash and equivalents has declined by 60.8% (from $3.63 million to $1.42 million).
- The most recent figure is from CHINA PHARMA HOLDINGS, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 1, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: